The SURMOUNT-MMO cardiovascular outcomes trial is ongoing
TB-500 is a synthetic fragment of thymosin beta-4, a protein involved in cell migration and repair
in December 2024 the FDA's Pharmacy Compounding Advisory Committee voted against adding it to the final 503A bulks list, citing nonclinical toxicity, an unresolved cardiac signal, and immunogenicity risk
to loosen regulations on peptides, which are often pitched as a quick way to build muscle, heal injuries or appear younger
Outcome measures include biomechanical testing (load to failure, stiffness), histological scoring (collagen organization, fibroblast density), and functional assessment (gait analysis, range of motion)
Neuroprotection & Brain Health BPC-157 has been shown to support brain function, reduce neuroinflammation, and enhance cognitive recovery